These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15965360)

  • 1. The anti-anginal drug trimetazidine reduces neutrophil-mediated cardiac reperfusion injury.
    Tritto I; Wang P; Kuppusamy P; Giraldez R; Zweier JL; Ambrosio G
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):89-98. PubMed ID: 15965360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts.
    Allibardi S; Chierchia SL; Margonato V; Merati G; Neri G; Dell'Antonio G; Samaja M
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):543-9. PubMed ID: 10410824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity studies on the protection of Trimetazidine derivatives modified with nitroxides and their precursors from myocardial ischemia-reperfusion injury.
    Kálai T; Khan M; Balog M; Kutala VK; Kuppusamy P; Hideg K
    Bioorg Med Chem; 2006 Aug; 14(16):5510-6. PubMed ID: 16697647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury.
    El Banani H; Bernard M; Cozzone P; James F; Feuvray D
    Am J Cardiol; 1998 Sep; 82(5A):25K-29K. PubMed ID: 9737483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts.
    Boucher FR; Hearse DJ; Opie LH
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):45-9. PubMed ID: 7521488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation.
    Shandelya SM; Kuppusamy P; Weisfeldt ML; Zweier JL
    Circulation; 1993 Feb; 87(2):536-46. PubMed ID: 8381059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation.
    Shen YC; Chen CF; Sung YJ
    Br J Pharmacol; 1999 Dec; 128(7):1593-601. PubMed ID: 10602341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling.
    Khan M; Meduru S; Mostafa M; Khan S; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2010 May; 333(2):421-9. PubMed ID: 20167841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine.
    Monti LD; Allibardi S; Piatti PM; Valsecchi G; Costa S; Pozza G; Chierchia S; Samaja M
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1122-30. PubMed ID: 11514278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
    Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
    Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits.
    Williams FM; Tanda K; Kus M; Williams TJ
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):828-33. PubMed ID: 7509900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
    Lopaschuk GD; Barr R; Thomas PD; Dyck JR
    Circ Res; 2003 Aug; 93(3):e33-7. PubMed ID: 12869392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine normalizes postischemic function of hypertrophied rat hearts.
    Saeedi R; Grist M; Wambolt RB; Bescond-Jacquet A; Lucien A; Allard MF
    J Pharmacol Exp Ther; 2005 Jul; 314(1):446-54. PubMed ID: 15840766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
    Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimetazidine-induced enhancement of myocardial recovery during reperfusion: a comparative study in diabetic and non-diabetic rat hearts.
    Ikizler M; Erkasap N; Dernek S; Batmaz B; Kural T; Kaygisiz Z
    Arch Med Res; 2006 Aug; 37(6):700-8. PubMed ID: 16824928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion.
    Pabla R; Buda AJ; Flynn DM; Blessé SA; Shin AM; Curtis MJ; Lefer DJ
    Circ Res; 1996 Jan; 78(1):65-72. PubMed ID: 8603507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts.
    Williams RE; Zweier JL; Flaherty JT
    Circulation; 1991 Mar; 83(3):1006-14. PubMed ID: 1847847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.